Bank Pictet & Cie (Europe)’s Teladoc Health TDOC Stock Holding History
Bought
Maintained
Sold
Other funds holding TDOC
AIM
NAMA
KA
CS
Bank Pictet & Cie (Europe)'s TDOC Position: Q1 2022 in Review
Bank Pictet & Cie (Europe) sold out of Teladoc Health (TDOC) in Q1 2022, closing a stake of 2,334 shares — an estimated $214K sold.
Bank Pictet & Cie (Europe) first reported a position in TDOC in Q1 2021 and held it in 4 quarters. The position peaked at $371K in Q2 2021. 680 funds tracked by Wall St. Rank hold TDOC as of Q1 2022.
- Bank Pictet & Cie (Europe) reported no remaining Teladoc Health position as of Q1 2022 after selling out during the quarter.
- Bank Pictet & Cie (Europe) sold 2,334 Teladoc Health shares in Q1 2022, an estimated $214K.
- Bank Pictet & Cie (Europe) first reported a position in Teladoc Health in Q1 2021 and held it in 4 quarters.
- Bank Pictet & Cie (Europe)'s Teladoc Health position peaked at $371K in Q2 2021.
- 680 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2022.
Based on Bank Pictet & Cie (Europe)'s 13F filing for Q1 2022, filed 4 May 2022.